Fire Capital Management LLC Takes $1.66 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fire Capital Management LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,170 shares of the medical equipment provider's stock, valued at approximately $1,655,000. Intuitive Surgical comprises 1.2% of Fire Capital Management LLC's portfolio, making the stock its 21st biggest holding.

A number of other hedge funds also recently made changes to their positions in ISRG. Norges Bank bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $2,401,493,000. Proficio Capital Partners LLC increased its position in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after acquiring an additional 948,902 shares during the period. Capital Research Global Investors increased its position in Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares during the period. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $313,769,000. Finally, Northern Trust Corp lifted its holdings in shares of Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after purchasing an additional 494,496 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.3%

Shares of Intuitive Surgical stock traded down $1.73 on Monday, hitting $550.62. 293,177 shares of the company traded hands, compared to its average volume of 1,641,195. Intuitive Surgical, Inc. has a 12-month low of $397.47 and a 12-month high of $616.00. The firm's 50-day simple moving average is $516.44 and its 200 day simple moving average is $538.55. The company has a market cap of $197.35 billion, a P/E ratio of 86.03, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the company earned $1.50 EPS. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent research reports. Citigroup restated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Robert W. Baird decreased their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Barclays cut their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Finally, Evercore ISI lowered their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $596.05.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the transaction, the senior vice president now directly owns 2,091 shares of the company's stock, valued at $1,114,879.38. The trade was a 18.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. This trade represents a 60.72% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 25,778 shares of company stock worth $12,867,197. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.